Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2023-03-03 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
230303 - Acquisition of own shares_ENG (final) - Copy.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly details the 'Acquisition of own shares' by UCB SA/NV, providing specific dates, the number of shares repurchased, and the average price paid, all under the framework of its 'Share Repurchase Program 2023'. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2023-03-03 English
230303 - Rachat d'actions propres_FR (final) - Copy.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres" (Share Buyback) and explicitly details the number of shares repurchased, the dates, and the average price paid, referencing the "Programme de rachat d'actions propres 2023" (2023 Share Buyback Program). This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is short (2952 chars) and it is a direct announcement of the transaction details, not an announcement of a future report.
2023-03-03 French
230303 - Verwerving van eigen aandelen_NL (final) - Copy.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving van eigen aandelen" (Acquisition of own shares) and details the purchase of UCB shares by a financial intermediary on behalf of the company under the 'Aandelen Inkoopprogramma 2023' (Share Buyback Program 2023). It provides specific transaction dates, quantities, and prices for shares bought back between February 27, 2023, and March 2, 2023. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document is a formal announcement (Gereglementeerde informatie) detailing this specific corporate action.
2023-03-03 Dutch
2022_Full-Year_Integrated_Annual_Report_0.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'Integrated Annual Report 2022' and contains comprehensive sections including management reports, consolidated financial statements, notes to the financial statements, auditor's reports, and corporate governance statements. It covers the full fiscal year 2022 and provides detailed financial and extra-financial performance data, fitting the definition of an Annual Report (10-K). FY 2022
2023-02-22 English
2022_Full-Year_Integrated_Annual_Report-FR.pdf
Annual Report Classification · 1% confidence The document is titled 'Rapport annuel intégré 2022' (2022 Integrated Annual Report) for UCB. It contains comprehensive financial statements, management reports, governance disclosures, and audit reports for the full fiscal year 2022. It is clearly the primary annual reporting document rather than an announcement or a summary, fitting the definition of a 10-K (Annual Report). FY 2022
2023-02-22 French
2022_Full-Year_Integrated_Annual_Report-NL.pdf
Annual Report Classification · 1% confidence The document is titled 'Geïntegreerd jaarverslag 2022' (Integrated Annual Report 2022) for UCB. It contains comprehensive financial statements, management reports, governance disclosures, and audit reports for the full fiscal year 2022. It is clearly the primary annual reporting document, not an announcement or a summary, and thus fits the definition of a 10-K (Annual Report). FY 2022
2023-02-22 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.